Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11787834 Glucocorticoid receptor agonists

Patent 11787834 was granted and assigned to Eli Lilly and Company on October, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Eli Lilly

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11787834

Patent Inventor Names

Takako Wilson

William Thomas McMillen

Adel Ahmed Rashad Ahmed

Jacqueline Mary Wurst

Jose Eduardo Lopez

Joshua Ryan Clayton

Ryan Edward Stites

Date of Patent

October 17, 2023

Patent Application Number

17700943

Date Filed

March 22, 2022

Patent Citations

‌

US Patent 8524697 C20-C21 substituted glucocorticoid receptor agonists

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11787834 Glucocorticoid receptor agonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API